We identified the IFA and the FCAs, through the use of antihuman VAPB polyclonal and monoclonal antibodies, respectively, the best techniques to detect VAPB aggregates that could represent a novel diagnostic device for ALS. This evidence concerns the gene VAPB and amyotrophic lateral sclerosis.